Peptide News Digest

#Maryland

1 story

Regulatory · View digest

Maryland Becomes the First State to Limit What Government Health Plans Pay for Ozempic and Jardiance

Maryland's Prescription Drug Affordability Board set upper payment limits on Ozempic and Jardiance for state and local government health plans, starting January 1, 2027, WYPR reported. Board staff estimate savings of about $6.1 million, and the step could let the board set limits for private insurance in 2028. Aimed Alliance warned the limits could change formularies and access, and the board said it would revise the policy if access suffers. Colorado's limit on Enbrel is blocked by a court order.